The Gly482Ser genotype at the PPARGC1A gene and elevated blood pressure: A meta-analysis involving 13,949 individuals

Journal of Applied Physiology

Volumn 105, Issue 4, 2008, Pages 1352-1358

  Vimaleswaran, Karani Santhanakrishnan ^a   Luan, Jian'an ^a   Andersen, Gitte ^b   Muller, Y Li ^c   Wheeler, Eleanor ^d   Brito, Ema C ^e   O'Rahilly, Stephen ^f   Pedersen, Oluf ^b   Baier, Leslie J ^c   Knowler, William C ^c   Barroso, Inês ^d   Wareham, Nicholas J ^a   Loos, Ruth J F ^a   Franks, Paul W ^a,e  

^a INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^b STENO DIABETES CENTER   (Denmark)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Gene environment interaction; Meta analysis

Indexed keywords

GLYCINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REACTIVE OXYGEN METABOLITE; SERINE; HEAT SHOCK PROTEIN; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNICITY; GENE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HUMAN; HYPERTENSION; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; AGE; BLOOD PRESSURE; BODY MASS; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEAT-SHOCK PROTEINS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TRANSCRIPTION FACTORS;

EID: 55449132300     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.90423.2008     Document Type: Article

References (26)

1. Ambye L, Rasmussen S, Fenger M, Jorgensen T, Borch-Johnsen K, Madsbad S, Urhammer SA. Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome. Diabetes Res Clin Pract 67: 175-179, 2005.
2. Andersen G, Wegner L, Jensen DP, Glumer C, Tarnow L, Drivsholm T, Poulsen P, Hansen SK, Nielsen EM, Ek J, Mouritzen P, Vaag A, Parving HH, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites. Hypertension 45: 565-570, 2005.
3. Barroso I, Luan J, Middelberg RP, Harding AH, Franks PW, Jakes RW, Clayton D, Schafer AJ, O'Rahilly S, Wareham NJ. Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action. PLoS Biol 1: E20, 2003.
4. Barroso I, Luan J, Sandhu M, Franks PW, Crowley V, Schafer A, O'Rahilly S, Wareham N. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes. Diabetologia 49: 501-505, 2006.
5. Chen S, Yan W, Huang J, Yang W, Gu D. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha polymorphism is not associated with essential hypertension and type 2 diabetes mellitus in Chinese population. Hypertens Res 27: 813-820, 2004.
6. Cheurfa N, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. The Gly482Ser polymorphism in the peroxisome proliferator- activated receptor-gamma coactivator-1 gene is associated with hypertension in type 2 diabetic men. Diabetologia 47: 1980-1983, 2004.
7. Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borck-Johnsen K, Hansen T, Pedersen O. Mutation analysis of peroxisome proliferator- activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 44: 2220-2226, 2000.
8. Franks PW, Bhattacharyya S, Luan J, Montague C, Brennand J, Challis B, Brage S, Ekelund U, Middelberg RP, O'Rahilly S, Wareham NJ. Association between physical activity and blood pressure is modified by variants in the G-protein coupled receptor 10. Hypertension 43: 224-228, 2004.
9. Franks PW, Ekelund U, Luan J, Brage S, Schaeffer PJ, O'Rahilly S, Barroso I, Wareham NJ. PPARGC1A coding variation may initiate impaired non-esterified fatty acid clearance during glucose challenge. Diabetologia 50: 569-573, 2007.
10. Franks PW, Knowler WC, Nair S, Koska J, Lee YH, Lindsay RS, Walker BR, Looker HC, Permana PA, Tataranni PA, Hanson RL. Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians. Hypertension 44: 681-688, 2004.
11. Franks PW, Loos RJ. PGC-1alpha gene and physical activity in type 2 diabetes mellitus. Exerc Sport Sci Rev 34: 171-175, 2006.
12. Franks PW, Luan J, Barroso I, Brage S, Sanchez JLG, Ekelund U, Rios MS, Schafer AJ, O'Rahilly S, Wareham NJ. Variation in the eNOS gene modifies the association between total energy expenditure and glucose intolerance. Diabetes 54: 2795-2801, 2005.
13. Franks PW. White-coat hypertension and risk of stroke: do the data really tell us what we need to know? Hypertension 45: 183-184, 2005.
14. Gauderman WJ, Morrison JM. QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies (Online). http://hydra.usc.edu/gxe [2006].
15. Lucia A, Gomez-Gallego F, Barroso I, Rabadan M, Bandres F, San Juan AF, Chicharro JL, Ekelund U, Brage S, Earnest CP, Wareham NJ, Franks PW. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J Appl Physiol 99: 344-348, 2005.
16. Muller YL, Bogardus C, Pedersen O, Baier L. A Gly482Ser missense mutation in the peroxisome proliferator-activated receptor gamma coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 52: 895-898, 2003.
17. Oberkofler H, Holzl B, Esterbauer H, Xie M, Iglseder B, Krempler F, Paulweber B, Patsch W. Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with hypertension in middle-aged men. Hypertension 41: 368-372, 2003.
18. Petrovic MG, Kunej T, Peterlin B, Dovc P, Petrovic D. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not. Diabetes Metab Res Rev 21: 470-474, 2005.
19. Ridderstrale M, Johansson LE, Rastam L, Lindblad U. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men. Diabetologia 49: 496-500, 2006.
20. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, Daly MJ, Hughes TE, Groop L, Altshuler D, Almgren P, Florez JC, Meyer J, Ardlie K, Bengtsson Bostrom K, Isomaa B, Lettre G, Lindblad U, Lyon HN, Melander O, Newton-Cheh C, Nilsson P, Orho-Melander M, Rastam L, Speliotes EK, Taskinen MR, Tuomi T, Guiducci C, Berglund A, Carlson J, Gianniny L, Hackett R, Hall L, Holmkvist J, Laurila E, Sjogren M, Sterner M, Surti A, Svensson M, Svensson M, Tewhey R, Blumenstiel B, Parkin M, Defelice M, Barry R, Brodeur W, Camarata J, Chia N, Fava M, Gibbons J, Handsaker B, Healy C, Nguyen K, Gates C, Sougnez C, Gage D, Nizzari M, Gabriel SB, Chirn GW, Ma Q, Parikh H, Richardson D, Ricke D, Purcell S. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316: 1331-1336, 2007.
21. Sookoian S, Garcia SI, Porto PI, Dieuzeide G, Gonzalez CD, Pirola CJ. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents. J Mol Endocrinol 35: 373-380, 2005.
22. Soyal S, Krempler F, Oberkofler H, Patsch W. PGC-1alpha: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes. Diabetologia 49: 1477-1488, 2006.
23. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, Handschin C, Zheng K, Lin J, Yang W, Simon DK, Bachoo R, Spiegelman BM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127: 397-408, 2006.
24. Vimaleswaran KS, Radha V, Ghosh S, Majumder PP, Deepa R, Babu HN, Rao MR, Mohan V. Peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians. Diabet Med 22: 1516-1521, 2005.
25. Vohl MC, Houde A, Lebel S, Hould FS, Marceau P. Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome. Mol Genet Metab 86: 300-306, 2005.
26. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678, 2007.